NDC 37000-813

Vicks NyQuil Severe Cold and Flu

Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, And Dextromethorphan Hydrobromide

Vicks NyQuil Severe Cold and Flu is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by The Procter & Gamble Manufacturing Company. The primary component is Acetaminophen; Phenylephrine Hydrochloride; Doxylamine Succinate; Dextromethorphan Hydrobromide.

Product ID37000-813_6eb260fa-cc22-22f7-e053-2a91aa0a43f3
NDC37000-813
Product TypeHuman Otc Drug
Proprietary NameVicks NyQuil Severe Cold and Flu
Generic NameAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, And Dextromethorphan Hydrobromide
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2014-07-21
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameThe Procter & Gamble Manufacturing Company
Substance NameACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE; DEXTROMETHORPHAN HYDROBROMIDE
Active Ingredient Strength325 mg/1; mg/1; mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 37000-813-24

12 BLISTER PACK in 1 CARTON (37000-813-24) > 2 TABLET, COATED in 1 BLISTER PACK
Marketing Start Date2014-07-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 37000-813-02 [37000081302]

Vicks NyQuil Severe Cold and Flu TABLET, COATED
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-07-21
Marketing End Date2020-06-08

NDC 37000-813-12 [37000081312]

Vicks NyQuil Severe Cold and Flu TABLET, COATED
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-07-21
Marketing End Date2020-06-08

NDC 37000-813-24 [37000081324]

Vicks NyQuil Severe Cold and Flu TABLET, COATED
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-07-21
Marketing End Date2020-06-08

NDC 37000-813-72 [37000081372]

Vicks NyQuil Severe Cold and Flu TABLET, COATED
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-07-21
Marketing End Date2018-06-18

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN325 mg/1

OpenFDA Data

SPL SET ID:55e0c0f1-c83c-4527-a796-7cb0ee9a0633
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1546881
  • Medicade Reported Pricing

    37000081324 VICKS NYQUIL SEVERE COLD-FLU

    Pricing Unit: EA | Drug Type:

    37000081312 VICKS NYQUIL SEVERE COLD-FLU

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Vicks NyQuil Severe Cold and Flu" or generic name "Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, And Dextromethorphan Hydrobromide"

    NDCBrand NameGeneric Name
    37000-812Vicks NyQuil Severe Cold and FluVicks NyQuil Severe Cold and Flu
    37000-815Vicks NyQuil Severe Cold and FluVicks NyQuil Severe Cold and Flu
    37000-518Vicks NyQuil Severe Cold and FluVicks NyQuil Severe Cold and Flu
    66715-9705Lil Drug Store NyQuil SevereAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide
    66715-9905NyQuil Severe Plus VapoCOOL Cold and FluAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide
    37000-523NyQuil Severe plus Vicks VapoCoolAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide
    52904-912NyQuil Severe Plus Vicks Vapocool Cold and Fluacetaminophen, phenylephrine hydrochloride, doxylamine succinate, and dextromethorphan hydrobromide
    37000-813Vicks NyQuil SevereAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide
    69423-986Vicks NyQuil VapoCOOL SevereAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide
    37000-921Vicks Sinex DAcetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.